阴式子宫切除术联合旋切术后隐匿性子宫恶性肿瘤的发生率
这项回顾性队列研究纳入3个学术医疗中心2008年1月1日至2015年8月31日期间接受全阴式子宫切除术的2296例女性,其中611例接受阴道旋切。旋切组隐匿性子宫恶性肿瘤发生率为0.82%(5例),包括IA期I级子宫内膜腺癌3例(0.49%)和低级别间质肉瘤2例(0.33%)。作者结论认为无保护阴道旋切似乎不负面影响预后。
要点
- 全阴式子宫切除术2296例中,611例接受阴道旋切,1685例未接受旋切。
- 旋切组隐匿性子宫恶性肿瘤发生率为0.82%(5例),含子宫内膜腺癌0.49%和低级别间质肉瘤0.33%。
- 5例旋切组恶性肿瘤患者平均无病生存随访分别为48.33个月和42.0个月,均无病存活。
核心结论
- 在接受阴道子宫切除术联合旋切的患者中,隐匿性子宫癌的发生率为0.82%。
- 无保护阴道旋切与阴道子宫切除术同时使用时似乎不负面影响患者预后或结局。
研究设计与样本
- 经机构审查委员会批准的回顾性队列研究(加拿大工作组分类II-2)。
- 研究在3个学术医疗中心进行,纳入2008年1月1日至2015年8月31日期间接受全阴式子宫切除术的所有女性。
- 共2296例女性接受全阴式子宫切除术,其中未旋切1685例,接受冷刀楔形切除阴道旋切611例。
- 所有需要旋切的患者子宫切除术指征均为良性。
主要发现
- 旋切组隐匿性子宫恶性肿瘤发生率为0.82%(5例),包括IA期I级子宫内膜腺癌3例(0.49%)和低级别间质肉瘤2例(0.33%)。
- 5例隐匿性恶性肿瘤患者平均年龄48.8岁,平均体重指数32.36 kg/m2,中位产次2。
- 5例旋切组恶性肿瘤患者的子宫切除术指征均为异常子宫出血,最终病理平均子宫重量231.60 g。
- 所有患者均保持无病状态,无死亡发生。
- 子宫内膜腺癌患者平均无病生存期48.33个月(范围33-67个月),间质肉瘤患者平均无病生存期42.0个月(范围19-65个月)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To determine the incidence and impact of occult uterine malignancy following vaginal hysterectomy and uncontained morcellation. DESIGN: An Institutional Review Board-approved retrospective cohort study (Canadian Task Force classification II-2). SETTING: Three academic medical centers. PATIENTS: All women who underwent vaginal hysterectomy between January 1, 2008, and August 31, 2015, at 3 institutions were considered for inclusion in the study. INTERVENTIONS: Total vaginal hysterectomy with and without morcellation. MEASUREMENTS AND MAIN RESULTS: A total of 2296 women underwent total vaginal hysterectomy without (n = 1685) or with (n = 611) vaginal morcellation performed via cold-knife wedge resection. All patients requiring morcellation had benign indications for hysterectomy. The incidence of occult uterine malignancy among hysterectomies requiring vaginal morcellation was 0.82% (n = 5) and included stage IA, grade I endometrial adenocarcinoma (n = 3; 0.49%) and low grade stromal sarcoma (n = 2; 0.33%). Demographic data for those with occult malignancy included mean age 48.8 years, mean body mass index 32.36 kg/m2, and median parity 2. Indication for hysterectomy was abnormal uterine bleeding for the 5 patients who underwent morcellation and were found to have a malignancy. Final pathology revealed a mean uterine weight of 231.60 g. All patients have remained disease-free, and no deaths have occurred. Mean disease-free survival was 48.33 months (range, 33-67 months) for the patients with endometrial adenocarcinoma and 42.0 months (range, 19-65 months) for the patients with stromal sarcoma for the 5 patients who underwent vaginal hysterectomy with morcellation. CONCLUSION: Among patients undergoing vaginal hysterectomy with morcellation, the incidence of occult uterine carcinoma is 0.82%. Uncontained vaginal morcellation when used concomitantly with vaginal hysterectomy does not appear to negatively impact patient prognosis or outcomes.
引用
- Wasson M, Magtibay P, Magtibay P, et al. Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy With Morcellation. J Minim Invasive Gynecol. 2017. PMID: 28254678. doi:10.1016/j.jmig.2017.01.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。